questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérocycliques avec 4 noyaux ou plus
Ergotamines
Ergotamines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Migraine
Diagnostic médical
Imagerie par résonance magnétique
Migraine
Critères diagnostiques
Migraine
Antécédents familiaux
Migraine
Symptômes
5
Variabilité des symptômes
Migraine
Prévention
5
Prévention des migraines
Déclencheurs de migraine
Régime alimentaire
Migraine
Exercice physique
Migraine
Thérapies alternatives
Migraine
Traitements
5
Ergotamines
Traitement de la migraine
Effets secondaires
Ergotamines
Efficacité du traitement
Ergotamines
Interactions médicamenteuses
Ergotamines
Voie d'administration
Ergotamines
Complications
5
Accident vasculaire cérébral
Migraine
Migraine chronique
Qualité de vie
Fonction cognitive
Migraine
Gestion des complications
Migraine
Facteurs de risque
5
Facteurs de risque
Migraine
Fluctuations hormonales
Migraine
Habitudes alimentaires
Migraine
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ergotamines : Questions médicales les plus fréquentes",
"headline": "Ergotamines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ergotamines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-26",
"dateModified": "2025-03-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ergotamines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"url": "https://questionsmedicales.fr/mesh/D006576",
"about": {
"@type": "MedicalCondition",
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"code": {
"@type": "MedicalCode",
"code": "D006576",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromocriptine",
"alternateName": "Bromocriptine",
"url": "https://questionsmedicales.fr/mesh/D001971",
"about": {
"@type": "MedicalCondition",
"name": "Bromocriptine",
"code": {
"@type": "MedicalCode",
"code": "D001971",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocornine",
"alternateName": "Dihydroergocornine",
"url": "https://questionsmedicales.fr/mesh/D025441",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocornine",
"code": {
"@type": "MedicalCode",
"code": "D025441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergocristine",
"alternateName": "Dihydroergocristine",
"url": "https://questionsmedicales.fr/mesh/D025442",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergocristine",
"code": {
"@type": "MedicalCode",
"code": "D025442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "alpha-Dihydroergocryptine",
"alternateName": "Dihydroergocryptine",
"url": "https://questionsmedicales.fr/mesh/D025443",
"about": {
"@type": "MedicalCondition",
"name": "alpha-Dihydroergocryptine",
"code": {
"@type": "MedicalCode",
"code": "D025443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotamine",
"alternateName": "Dihydroergotamine",
"url": "https://questionsmedicales.fr/mesh/D004087",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydroergotoxine",
"alternateName": "Dihydroergotoxine",
"url": "https://questionsmedicales.fr/mesh/D004088",
"about": {
"@type": "MedicalCondition",
"name": "Dihydroergotoxine",
"code": {
"@type": "MedicalCode",
"code": "D004088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"alternateName": "Ergoloid Mesylates",
"url": "https://questionsmedicales.fr/mesh/D004877",
"about": {
"@type": "MedicalCondition",
"name": "Mésilate d'alcaloïdes hydrogénés de l'ergot",
"code": {
"@type": "MedicalCode",
"code": "D004877",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.400.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ergotamine",
"alternateName": "Ergotamine",
"url": "https://questionsmedicales.fr/mesh/D004878",
"about": {
"@type": "MedicalCondition",
"name": "Ergotamine",
"code": {
"@type": "MedicalCode",
"code": "D004878",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.400.562.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ergotamines",
"alternateName": "Ergotamines",
"code": {
"@type": "MedicalCode",
"code": "D004879",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Manoj B Kudupoje",
"url": "https://questionsmedicales.fr/author/Manoj%20B%20Kudupoje",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Eric S Vanzant",
"url": "https://questionsmedicales.fr/author/Eric%20S%20Vanzant",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Kyle R McLeod",
"url": "https://questionsmedicales.fr/author/Kyle%20R%20McLeod",
"affiliation": {
"@type": "Organization",
"name": "Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States."
}
},
{
"@type": "Person",
"name": "Alexandros Yiannikouris",
"url": "https://questionsmedicales.fr/author/Alexandros%20Yiannikouris",
"affiliation": {
"@type": "Organization",
"name": "Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States."
}
},
{
"@type": "Person",
"name": "Wiebke Rudolph",
"url": "https://questionsmedicales.fr/author/Wiebke%20Rudolph",
"affiliation": {
"@type": "Organization",
"name": "a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "4-Thioribose Analogues of Adenosine Diphosphate Ribose (ADPr) Peptides.",
"datePublished": "2023-06-20",
"url": "https://questionsmedicales.fr/article/37338412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.orglett.3c01554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utilization Trends In Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor and Cost Among Medicare Beneficiaries.",
"datePublished": "2023-01-20",
"url": "https://questionsmedicales.fr/article/36690313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cpcardiol.2023.101608"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Oral Anticoagulation and Adenosine Diphosphate Inhibitor Therapies on Short-term Outcome of Traumatic Brain Injury.",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35764401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1212/WNL.0000000000200834"
}
},
{
"@type": "ScholarlyArticle",
"name": "Selective turn-on sensing of adenosine diphosphate and phosphate anions by ruthenium (II) polypyridine anchored p-tert-butylcalix[4]arene platform.",
"datePublished": "2023-10-02",
"url": "https://questionsmedicales.fr/article/37804708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.saa.2023.123483"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Combination therapy with poly(adenosine diphosphate-ribose) polymerase (PARPi) and androgen receptor signaling pathway (ARPi) inhibitors for metastatic castration-resistant prostate cancer].",
"datePublished": "2023-11-17",
"url": "https://questionsmedicales.fr/article/37978072",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-023-02230-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérocycliques avec 4 noyaux ou plus",
"item": "https://questionsmedicales.fr/mesh/D006576"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ergotamines",
"item": "https://questionsmedicales.fr/mesh/D004879"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ergotamines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ergotamines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ergotamines",
"description": "Comment diagnostiquer une migraine ?\nQuels tests sont utilisés pour les migraines ?\nLes ergots sont-ils prescrits pour d'autres maux de tête ?\nQuels critères sont utilisés pour le diagnostic ?\nLes antécédents familiaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Adenosine+Diphosphate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ergotamines",
"description": "Quels sont les symptômes d'une migraine ?\nLes migraines provoquent-elles des vomissements ?\nY a-t-il des signes avant-coureurs de migraine ?\nLes migraines peuvent-elles causer des vertiges ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Adenosine+Diphosphate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ergotamines",
"description": "Comment prévenir les migraines ?\nLes changements alimentaires aident-ils à prévenir les migraines ?\nLe stress influence-t-il la fréquence des migraines ?\nLes exercices physiques aident-ils à prévenir les migraines ?\nLes thérapies alternatives sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Adenosine+Diphosphate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ergotamines",
"description": "Comment les ergots soulagent-ils les migraines ?\nQuels sont les effets secondaires des ergots ?\nLes ergots sont-ils efficaces pour tous les patients ?\nPeut-on combiner les ergots avec d'autres médicaments ?\nQuelle est la voie d'administration des ergots ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Adenosine+Diphosphate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ergotamines",
"description": "Quelles sont les complications possibles des migraines ?\nLes migraines peuvent-elles entraîner des AVC ?\nLes migraines chroniques ont-elles des conséquences ?\nLes migraines peuvent-elles causer des problèmes cognitifs ?\nComment gérer les complications des migraines ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Adenosine+Diphosphate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ergotamines",
"description": "Quels sont les facteurs de risque des migraines ?\nL'âge influence-t-il le risque de migraines ?\nLes changements hormonaux affectent-ils les migraines ?\nLe manque de sommeil est-il un facteur de risque ?\nLes habitudes alimentaires influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D004879?mesh_terms=Adenosine+Diphosphate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une migraine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique des symptômes et des examens neurologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les migraines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM peuvent être utilisés pour exclure d'autres causes."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils prescrits pour d'autres maux de tête ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont principalement prescrits pour les migraines, pas pour d'autres types de céphalées."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence, la durée et l'intensité des crises de migraine."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de migraines peuvent augmenter la probabilité de diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une migraine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs pulsatiles, des nausées et une sensibilité à la lumière."
}
},
{
"@type": "Question",
"name": "Les migraines provoquent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements peuvent accompagner les migraines chez certains patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes avant-coureurs de migraine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles visuels ou des picotements peuvent précéder une migraine."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des vertiges ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent des vertiges ou des étourdissements pendant une crise."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir les migraines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs connus, maintenir un mode de vie sain et prendre des médicaments préventifs."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires aident-ils à prévenir les migraines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments peuvent déclencher des migraines, leur évitement peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la fréquence des migraines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress est un déclencheur courant des migraines et sa gestion est cruciale."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils à prévenir les migraines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité physique régulière peut réduire la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les thérapies alternatives sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines thérapies comme l'acupuncture peuvent aider à réduire la fréquence des migraines."
}
},
{
"@type": "Question",
"name": "Comment les ergots soulagent-ils les migraines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots agissent en constrictant les vaisseaux sanguins et en réduisant l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des ergots ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des vertiges et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Les ergots sont-ils efficaces pour tous les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité peut varier et certains patients peuvent ne pas y répondre."
}
},
{
"@type": "Question",
"name": "Peut-on combiner les ergots avec d'autres médicaments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, mais il est important de consulter un médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Quelle est la voie d'administration des ergots ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les ergots peuvent être administrés par voie orale, nasale ou injectable selon le cas."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des migraines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles de l'humeur, des problèmes de sommeil et des AVC."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles entraîner des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines avec aura peuvent augmenter le risque d'accident vasculaire cérébral."
}
},
{
"@type": "Question",
"name": "Les migraines chroniques ont-elles des conséquences ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent affecter la qualité de vie et entraîner des troubles psychologiques."
}
},
{
"@type": "Question",
"name": "Les migraines peuvent-elles causer des problèmes cognitifs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les migraines fréquentes peuvent affecter la cognition."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des migraines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins et psychologues est souvent nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des migraines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, le sexe féminin, et le stress."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de migraines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les migraines sont plus fréquentes chez les jeunes adultes et les femmes d'âge moyen."
}
},
{
"@type": "Question",
"name": "Les changements hormonaux affectent-ils les migraines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les fluctuations hormonales, notamment pendant le cycle menstruel, peuvent déclencher des migraines."
}
},
{
"@type": "Question",
"name": "Le manque de sommeil est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le manque de sommeil peut augmenter la fréquence et l'intensité des migraines."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments et boissons peuvent déclencher des migraines chez certaines personnes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States.
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Department of Animal and Food Sciences, University of Kentucky, W.P. Garrigus Building, Lexington, Kentucky 40546-0215, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
Chemistry and Toxicology Division, Center for animal Nutrigenomics & Applied Animal Nutrition, Alltech Inc., 3031 Catnip Hill Road, Nicholasville, Kentucky 40356, United States.
Publications dans "Ergotamines" :
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
2 publications dans cette catégorie
Affiliations :
a Institute of Forensic Medicine , Jena University Hospital , Jena , Germany.
Publications dans "Ergotamines" :
Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems
2019-01-09
Liquid chromatography-mass spectrometry-based determination of ergocristine, ergocryptine, ergotamine, ergovaline, hypoglycin A, lolitrem B, methylene cyclopropyl acetic acid carnitine, N-acetylloline, N-formylloline, paxilline, and peramine in equine hair.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
2019-04-05
1 publication dans cette catégorie
Affiliations :
Division 1.7, Organic Trace and Food Analysis, Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. 11, 12489 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Food Chemistry and Toxicology, Technische Universität Berlin, Gustav-Meyer-Allee 25, 13355 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Division 1.7, Organic Trace and Food Analysis, Bundesanstalt für Materialforschung und-prüfung (BAM), Richard-Willstätter-Str. 11, 12489 Berlin, Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences, KIIT University, Bhubaneshwar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Urology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Department of Gastroenterology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
1 publication dans cette catégorie
Affiliations :
Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Publications dans "Ergotamines" :
Adenosine diphosphate (ADP) ribosylation is an important post-translational modification (PTM) that plays a role in a wide variety of cellular processes. To study the enzymes responsible for the estab...
Recent guidelines regarding acute coronary syndrome (ACS) have advocated for use of prasugrel and ticagrelor over clopidogrel for acute coronary syndrome. However, analyses from multiple databases hav...
Usage of oral anticoagulants (OACs) or adenosine diphosphate inhibitors (ADPi) is known to increase the risk of bleeding. We aimed to investigate the impact of OAC and ADPi therapies on short-term out...
All adult patients hospitalized for TBI in Finland during 2005-2018 were retrospectively studied using a combination of national registries. Usage of pharmacy-purchased OACs and ADPi at the time of TB...
The study population included 57,056 persons (mean age 66 years) of whom 0.9% used direct OACs (DOACs), 7.1% vitamin K antagonists (VKA), and 2.3% ADPi. Patients with VKAs had higher case-fatality tha...
Preinjury use of VKA is associated with increases in short-term mortality and in need for ANOs after TBI. DOACs are associated with lower fatality than VKAs after TBI. ADPi were not independently asso...
This study provides Class II evidence that among adults with TBI, mortality was significantly increased in those using VKAs but not in those using DOACs or ADPi....
Nucleoside polyphosphate (NPP) anions are important for enzymatic activity and should be monitored by scientists in industry and medicine. By elucidating enzyme kinetics and processes, it aids in the ...
However, a discriminative turn-on fluorescent property is exhibited by non-fluorescent p-tertbutylcalix[4]arene modified 1,2,3-triazole containing bis-ruthenium polypyridyl complex (RL) upon the addit...
The calix[4]arene macrocycle's excellent size and binding cone conformation make it a good host-guest interface for the pyrophosphate anion and ADP. The bis-ruthenium polypyridyl complex's connection ...
Metastatic castration-resistant prostate cancer (mCRPC) is a heterogeneous disease with varying clinical and molecular subtypes. Almost one-third of patients have abnormalities in homologous recombina...
To compare radiographic progression-free survival (rPFS), overall survival (OS), and treatment-emergent adverse events (TEAEs) among patients with metastatic castrate-resistant prostate cancer (mCRPC)...
We conducted a systematic review/meta-analysis of all published Phase III randomised controlled trials using EMBASE, MEDLINE, and Cochrane (inception until 6 June 2023). Published full-text manuscript...
Three trials were identified: PROpel, MAGNITUDE, and TALAPRO-2. Compared to placebo/ARAT, the PARPi/ARAT combination was associated with a 35% rPFS improvement in the overall cohort (HR 0.65, 95% CI 0...
The addition of PARPi to ARAT in the first-line mCRPC setting is associated with rPFS benefits across subgroups, with the greatest magnitude of benefit in BRCA1/2m patients. OS benefits remain inconsi...
BRCA1 c.5096G>A (p. Arg1699Gln) (hereinafter BRCA1 R1699Q) is classified as a pathogenic genetic variant despite its lower penetrance of breast and ovarian cancers compared to other BRCA1 variants. Ho...
We present a case of stage IIIc high-grade primary peritoneal cancer in a 69-year-old woman with germline BRCA1 R1699Q variant. She received platinum-containing chemotherapy followed by surgery. Eight...
This is the first report of the clinical outcome of PARP inhibitor and platinum-containing chemotherapy in a patient with a BRCA1 R1699Q variant. Despite BRCA1 mutation and high GIS, used as indicator...
Nucleoside diphosphate kinases (NDPKs) are encoded by...
Several experimental studies have linked adenosine's neuroprotective role in cerebral ischemia. During ischemia, adenosine is formed due to intracellular ATP breakdown into ADP, further when phosphate...
Ion channel activation upon ligand gating triggers a myriad of biological events and, therefore, evolution of ligand gating mechanism is of fundamental importance. TRPM2, a typical ancient ion channel...